Take a look at the presentations of the main scientific sessions!

For all details about the speakers, sessions, oral abstract presentations, posters, and special sessions please check the iPlanner:


Please note: all times are shown in Central European Summer Time (CEST).

Wednesday, May 5, 2021


Pre-Meeting Symposium: Living Donor Transplantation: Beyond Surgery

Session 1: The LDLT Donor I

  • Accepting a steatotic right lobe living donor – Limits, preparation, and role of defatting cocktails
  • Safe use of low GRWR grafts
  • Debates in LDLT – Minimally invasive donor hepatectomy: Laparoscopic vs. robotic

Session 2: The LDLT Donor II

  • Complex biliary anatomy: Short- and long-term risks for the donor
  • Long term psychosocial follow-up of donors post donor hepatectomy: An essential aspect

Session 3: The LDLT Recipient I

  • Donor biliary problems, incidence, treatment, outcomes and preventions
  • Evaluation and selection of patients with tumours beyond conventional criteria (UCSF): Should the criteria be different for LDLT?
  • Debates in LDLT: Arterial reconstruction: Microscope vs. Loupes – Does it make a difference?
  • Debates in LDLT – What matters in Small for Size Syndrome in LDLT: Portal flow vs. pressure

Session 4: The LDLT Recipient II – Surgical Innovations in LDLT (Video Lectures)

  • Intraoperative management of PVT: Different scenarios, different solutions
  • Bench reconstruction of complex venous outflow
  • Multiple bile ducts: How to deal with them


Pathology Workshop

Oncology Section

  • Transplant oncology: Current status including tumor types and peri LT treatment, and future perspectives. What can a liver surgeon expect from a pathologist?
  • Tumor pathology of HCC, combined HCC-CCA, iCCA and metastatic tumor: Tumor diagnosis including diagnostic pitfalls, macro/micro classification and inter/intra tumoral heterogeneity
  • Chemotherapy-induced liver injury (steatohepatitis, NRH, SOS): Pathological features and clinical impact

Non-Oncology Section

  • Diagnosis and assessment of disease severity as well as post LT recurrence in chronic liver disease patients. What can a liver surgeon expect from a pathologist?
  • Chronic liver diseases (viral hepatitis, AIH, PSC, PBC) and acute liver failure in pre- and post-LT patients
  • Fatty liver diseases including (non) alcoholic- steatohepatitis : definition and pathological features in pre- and post-LT patients


Basic Science Workshop: From Clinical Liver Transplantation to Personalized Patient Care: Omics, Artificial Intelligence and Experimental Models

  • The A_B_C of liver transplant research: Starting a lab for liver transplantation research, from basic science to precision medicine
  • Basic science
  • Translational science
  • The multi-omics era: Identifying strategies that will benefit specific research questions in liver transplantation
  • Different omics strategies: Pros and cons
  • Big data analyses
  • What experimental models can I set up for personalized medicine?
  • Small animal models
  • Large animal models
  • New advances in liver transplantation science
  • How do I publish basic science papers in liver transplantation? – What is Transplantation Journal’s position as the official journal of ILTS to accept basic science papers?


Thursday, May 6, 2021


Featured Symposium: Anesthesia/Critical Care

  • Obesity and LT: New prospective
  • High-risk donor liver transplantation: Perioperative challenges and outcome
  • Sarcopenia and nutritional status in LT: Criteria for not pursuing transplantation
  • Cerebral hemodynamic in cirrhosis


Featured Symposium: Machine Perfusion: Do We Have the Answer?

  • Overview of current clinical machine perfusion strategies
  • General or selective use: Which grafts require machine perfusion?
  • Graft viability testing and treatment options during normothermic machine perfusion vs. hypothermic machine perfusion
  • The essentials for future clinical trial designs in machine perfusion


Vanguard Featured Symposium

  • Risk stratification and prediction of mortality in LT for ACLF
  • Preoperative organ optimization for neurological renal and pulmonary system before LT in ACLF
  • Living donor selection in high urgency situation for ACLF
  • Debate: Should LDLT be performed for alcohol-induced ACLF


LICAGE/Anesthesia/Critical Care Parallel Symposium: Pre-op

  • Peri-operative sodium and LT: Should we manage it or should we let it go?
  • Do we transplant patient with ACLF 3?
  • Timing of dialysis in AKI – early vs. late?
  • Cardiomyopathies in ESLD: Screening, management and contraindication for LT


Plenary Session I

  • Hyponatremia is associated with increased mortality in pediatric patients on the waiting list for liver transplantation
  • Radiomics to predict aggressive hepatocellular carcinoma features in liver transplantation
  • Delayed kidney transplant (KT) up to 2 days in combined liver-kidney transplantation (CLKT) offers similar renal function as KT alone: comparison analysis with mate kidneys
  • Proteinase3 contributes to hepatic ischemia reperfusion injury through promoting neutrophil inflammatory response
  • Liver transplant, liver resection or ablation as first-line treatment for solitary HCC 3 cm or less: an Intention-to-treat analysis
  • Reassessment of the risk of recurrence (R3) after liver transplantation for HCC: validation of the R3 score and comparison with existing models
  • Time-trends in patient mortality and graft survival of patients receiving a DCD or DBD liver transplantation in the UK and Ireland between 2008 and 2016
  • Post-normothermic perfusion sepsis: defining a new clinical syndrome
  • Utility and outcome of swap transplantation at a large volume living donor liver transplantation center


Featured Symposium: The Digital Liver Transplant Patient

  • Real-time quality assessment
  • Big Data? Big help or hype?
  • Robotics as an emerging technology in transplant surgery
  • Innovative applications for long-term quality control


Friday, May 7, 2021


LICAGE/Anesthesia/Critical Care Parallel Symposium: Intra-op

  • Prevention and management of intra-operative fibrinolysis: Controversy and new trends
  • Haemodynamic goals and intra-operative management of systemic hemodynamics
  • Intra-operative cardiac disasters
  • Intra-operative management of pulmonary hypertension


ELITA and TASL Joint Symposium I: HBV and Liver Transplantation

  • What is the role and rational for HBIG in prevention of HBV recurrence in 2021
  • Clinical case presentation
  • HBIG-free NA-based monoprophylaxis: Who and when?
  • Clinical case presentation
  • Key points of the ELITA HBV and LT Practice Guidelines
  • Clinical investigation in HBV LT candidates: Assessment of the evidence and future prospects


Parallel Session for Pediatrics I: Liver Transplantation for Pediatric Metabolic Liver Diseases

  • Management and indication of liver transplantation for urea cycle disease and organic acidemia
  • Liver transplantation in PFIC 1
  • Considerations for auxiliary liver transplantation in pediatric metabolic liver disease
  • Future treatment of metabolic liver disease using human iPS hepatic bud


Featured Symposium: Topics Without Consensus

  • Acute alcoholic hepatitis
  • Recreational drug use /opioid use in transplant patients
  • Obesity and frailty: Mutually exclusive?
  • Artificial liver support: a bridge or substitute to LT for acute liver failure


LICAGE/Anesthesia/Critical Care Parallel Symposium: Post-op

  • Management of failing graft
  • Graft-versus-host disease in LT – Something we can learn from bone marrow transplantation
  • Management of postoperative infections
  • Hemostatic changes in cirrhotic patients with sepsis


ELITA Symposium II: Acute on Chronic Liver Failure and LT

  • Introduction: ELITA CLIF European retrospective cohort on ACLF
  • The issue of futility: Are ACLF grade 3 patients too sick to be transplanted?
  • Prognosis of ACLF in patients listed for transplantation: Timing and implications for organ allocation in the MELD era
  • Surgical challenges in liver transplantation for ACLF: Is partial grafting (split and LDLT) a reasonable option?
  • ACLF in LT candidates: A challenge for intensivists and anesthesiologists


Parallel Session for Pediatrics II: Pediatric Liver Transplantation with Extrahepatic Involvements

  • When is liver and kidney transplantation a necessity in pediatric setting?
  • Fontan-associated liver cirrhosis: Role of the liver transplant surgeon
  • Encephalopathy and neuromonitoring in pediatric acute liver failure
  • Hepatopulmonary syndrome in pediatric liver transplantation


Plenary Session II

  • Predicting graft function after liver transplantation: validating the role of lactate at the end of transplant
  • Single-cell RNA sequencing reveals gene expression profiling of ischemia reperfusion injury
  • Sarco-model, a novel score to better predict the risk of death in cirrhotic patients awaiting liver transplantation
  • Pure laparoscopic versus open right hepatectomy in live liver donors: a propensity score matched analysis
  • Clonal evolution of recurrent hepatocellular carcinoma post-transplant and dependence on the immune environment
  • Myeloid-derived suppressor cells mobilization through CXCL1-CXCR2 signaling facilitates tumor recurrence after liver transplantation
  • CT based sarcopenia assessment & frailty scores are better than PELD in predicting early morbidity and mortality after pediatric live donor liver transplantation
  • The efficacy of ischemia-free liver transplantation in the treatment of end-stage liver disease in a prospective, randomized, controlled trial: a report of first 25 cases
  • Survival outcomes after liver transplantation for intrahepatic cholangiocarcinoma


Saturday, May 8, 2021


Featured Symposium: Transplant Oncology

  • Transplant immunology links to transplant oncology
  • Update on neoadjuvant strategies for liver cancer (CC and HCC)
  • Surgical perspective
  • New treatment options
  • Surgical resection
  • Transplant


Featured Symposium: Maintaining Excellence

  • What are the requirements of fellowship training: Lessons to learn from established transplant systems
  • Surgery
  • Hepatology
  • The effects of regulations on fellowship training – Panel discussion
  • Surgery
  • Hepatology
  • Critical Care/Anesthesia
  • What are the expectations of the trainees instructors and mentors? (Fellow perspective/Program director perspective)


Featured Symposium: Liver Transplantation in 2021

  • Does Meld/Na Meld remain a useful allocation system in 2021?
  • Protocols in immunosuppression after three decades: When and how?
  • What are new treatment options for Small for Size Syndrome in 2021?
  • Impact of liver donation on quality of life


Rising Star Plenary Session

  • Clinical and immunopathological features of two distinctive types of plasma-cell rich hepatitis: plasma-cell rich rejection and autoimmune hepatitis
  • Myosteatosis and its impact on graft- and patient survival in adult recipients of deceased donor liver transplantation
  • TLR4 induced PD-1 expression on myeloid dendritic cells promotes post-transplant HCC recurrence
  • Plasma microbiome profiles of liver transplant patients with operational tolerance
  • The beneficial intention-to-treat survival effect of living donation in patients with hepatocellular cancer waiting for liver transplantation

CME Credits

The 2021 Virtual International Congress of ILTS, ELITA and LICAGE, Berlin (streamed live), Germany, 05/05/2021- 08/05/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 20 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.


Please do not hesitate to contact us for further information about the program:

Scientific Secretariat

Jana Mruck
Phone: +49 30 24603 364
Email: scientific@2021.ilts.org


The official language of the Congress is English.